WT1 and astrocytic tumor: Using IHC, this study investigates the accuracy of WT1 (clone 6F-H2) to differentiate reactive astrogliosis from astrocytic tumors and to characterize different grades and histopathologic types of astrocytic tumors (according to the WHO classification 2016).